BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 20932306)

  • 1. Effect of neutrophil elastase and its inhibitor EPI-hNE4 on transepithelial sodium transport across normal and cystic fibrosis human nasal epithelial cells.
    Prulière-Escabasse V; Clerici C; Vuagniaux G; Coste A; Escudier E; Planès C
    Respir Res; 2010 Oct; 11(1):141. PubMed ID: 20932306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel neutrophil elastase inhibitor prevents elastase activation and surface cleavage of the epithelial sodium channel expressed in Xenopus laevis oocytes.
    Harris M; Firsov D; Vuagniaux G; Stutts MJ; Rossier BC
    J Biol Chem; 2007 Jan; 282(1):58-64. PubMed ID: 17090546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport.
    Caldwell RA; Boucher RC; Stutts MJ
    Am J Physiol Lung Cell Mol Physiol; 2005 May; 288(5):L813-9. PubMed ID: 15640288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Protease-Epithelial Sodium Channel Signaling Improves Mucociliary Function in Cystic Fibrosis Airways.
    Reihill JA; Walker B; Hamilton RA; Ferguson TE; Elborn JS; Stutts MJ; Harvey BJ; Saint-Criq V; Hendrick SM; Martin SL
    Am J Respir Crit Care Med; 2016 Sep; 194(6):701-10. PubMed ID: 27014936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
    Mroz MS; Harvey BJ
    Steroids; 2019 Nov; 151():108461. PubMed ID: 31344409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
    Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
    J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures.
    Hobbs CA; Blanchard MG; Alijevic O; Tan CD; Kellenberger S; Bencharit S; Cao R; Kesimer M; Walton WG; Henderson AG; Redinbo MR; Stutts MJ; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2013 Dec; 305(12):L990-L1001. PubMed ID: 24124190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMPK agonists ameliorate sodium and fluid transport and inflammation in cystic fibrosis airway epithelial cells.
    Myerburg MM; King JD; Oyster NM; Fitch AC; Magill A; Baty CJ; Watkins SC; Kolls JK; Pilewski JM; Hallows KR
    Am J Respir Cell Mol Biol; 2010 Jun; 42(6):676-84. PubMed ID: 19617399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.
    Webster MJ; Reidel B; Tan CD; Ghosh A; Alexis NE; Donaldson SH; Kesimer M; Ribeiro CMP; Tarran R
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30190268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures.
    Tan CD; Hobbs C; Sameni M; Sloane BF; Stutts MJ; Tarran R
    J Physiol; 2014 Dec; 592(23):5251-68. PubMed ID: 25260629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPX-101 is stable in and retains function after exposure to cystic fibrosis sputum.
    Sesma JI; Wu B; Stuhlmiller TJ; Scott DW
    J Cyst Fibros; 2019 Mar; 18(2):244-250. PubMed ID: 29936069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.
    Tarran R; Sabater JR; Clarke TC; Tan CD; Davies CM; Liu J; Yeung A; Garland AL; Stutts MJ; Abraham WM; Phillips G; Baker WR; Wright CD; Wilbert S
    Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L746-56. PubMed ID: 23542952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-mobility group box-1 increases epithelial sodium channel activity and inflammation via the receptor for advanced glycation end products.
    Grant GJ; Liou TG; Paine R; Helms MN
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C570-C580. PubMed ID: 31913693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostasin, a membrane-anchored serine peptidase, regulates sodium currents in JME/CF15 cells, a cystic fibrosis airway epithelial cell line.
    Tong Z; Illek B; Bhagwandin VJ; Verghese GM; Caughey GH
    Am J Physiol Lung Cell Mol Physiol; 2004 Nov; 287(5):L928-35. PubMed ID: 15246975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A segment of gamma ENaC mediates elastase activation of Na+ transport.
    Adebamiro A; Cheng Y; Rao US; Danahay H; Bridges RJ
    J Gen Physiol; 2007 Dec; 130(6):611-29. PubMed ID: 17998393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
    Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
    Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium.
    Saint-Criq V; Kim SH; Katzenellenbogen JA; Harvey BJ
    PLoS One; 2013; 8(11):e78593. PubMed ID: 24223826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis.
    Myerburg MM; Butterworth MB; McKenna EE; Peters KW; Frizzell RA; Kleyman TR; Pilewski JM
    J Biol Chem; 2006 Sep; 281(38):27942-9. PubMed ID: 16873367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.
    Garland AL; Walton WG; Coakley RD; Tan CD; Gilmore RC; Hobbs CA; Tripathy A; Clunes LA; Bencharit S; Stutts MJ; Betts L; Redinbo MR; Tarran R
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):15973-8. PubMed ID: 24043776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways.
    Hobbs CA; Blanchard MG; Kellenberger S; Bencharit S; Cao R; Kesimer M; Walton WG; Redinbo MR; Stutts MJ; Tarran R
    FASEB J; 2012 Oct; 26(10):4348-59. PubMed ID: 22798424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.